Allakos Inc ALLK:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 02/03/23 EST
7.20quote price arrow down-0.01 (-0.14%)
Volume
10,203
Close
7.21quote price arrow down-0.36 (-4.76%)
Volume
409,258
52 week range
2.54 - 8.73
Loading...
  • Open7.48
  • Day High7.70
  • Day Low7.20
  • Prev Close7.57
  • 52 Week High8.73
  • 52 Week High Date01/03/23
  • 52 Week Low2.54
  • 52 Week Low Date06/16/22

Key Stats

  • Market Cap614.318M
  • Shares Out85.20M
  • 10 Day Average Volume0.62M
  • Dividend-
  • Dividend Yield-
  • Beta0.46
  • YTD % Change-14.37

KEY STATS

  • Open7.48
  • Day High7.70
  • Day Low7.20
  • Prev Close7.57
  • 52 Week High8.73
  • 52 Week High Date01/03/23
  • 52 Week Low2.54
  • 52 Week Low Date06/16/22
  • Market Cap614.318M
  • Shares Out85.20M
  • 10 Day Average Volume0.62M
  • Dividend-
  • Dividend Yield-
  • Beta0.46
  • YTD % Change-14.37

RATIOS/PROFITABILITY

  • EPS (TTM)-6.76
  • P/E (TTM)-1.07
  • Fwd P/E (NTM)-3.47
  • EBITDA (TTM)-364.429M
  • ROE (TTM)-85.49%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date02/27/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Allakos Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Allakos Inc. is a clinical stage biotechnology company. The Company is developing therapeutics, which target immunomodulatory receptors present on immune effector cells involved in allergy, inflammatory, and proliferative diseases. Its advanced antibodies are lirentelimab (AK002) and AK006. AK002 selectively targets both mast cells and eosinophils, two types of white blood cells that are widely distributed in the body and play a central role in the inflammatory response. It...
Daniel Janney
Independent Chairman of the Board
Robert Alexander Ph.D.
Chief Executive Officer, Director
Adam Tomasi Ph.D.
President, Chief Operating Officer
Baird Radford
Chief Financial Officer
Address
825 INDUSTRIAL ROAD, SUITE 500
San Carlos, CA
94070
United States

Top Peers

SYMBOLLASTCHG%CHG
VKTX
Viking Therapeutics Inc
9.10-0.09-0.98%
CBAY
Cymabay Therapeutics Inc
8.55+0.02+0.23%
ALT
Altimmune Inc
15.16+0.12+0.80%
AVTE
Aerovate Therapeutics Inc
24.51+0.12+0.49%
EWTX
Edgewise Therapeutics Inc
10.75-0.05-0.46%